California lawmakers adopted a drug price transparency bill and several other key health care measures as their legislative session ended last week, but they pushed off decisions on some big-name proposals such as single-payer health care.
The proposal, which is headed to the desk of Gov. Jerry Brown, would impose new reporting requirements on drugmakers and health plans but wouldn’t have the power to bring down prices directly.
Several state-based exchanges and the District of Columbia will allow people more than the 45 days set by the Trump administration.
Varios estados evitarán este año una nueva regla de la administración Trump que reduce a la mitad el tiempo que los consumidores tienen para comprar un seguro médico individual en los mercados establecidos por ACA.
State lawmakers in California have an answer: legislation that would require your new insurer to keep paying for your current doctors even if they’re not in the network.
The increase — 46 percent over the past eight years — isn’t because the number of new kidney failure cases is rising. It’s because dialysis patients are living longer.
The nation’s second-largest insurer is shrinking its presence on Obamacare exchanges and in the broader individual market in response to prevailing uncertainty. California is just the latest — and the biggest — example.
The figure could be higher if President Trump ends an important consumer subsidy, which he has threatened to do. Anthem Blue Cross will pull out of the exchange and the overall individual market in 16 of 19 regions in the state.
La evidencia está mostrando que los deducibles altos han obligado a la gente a retrasar atención que podría prevenir emergencias de salud más tarde, o mejorar su calidad de vida.
The number of Americans with high-deductible health plans is growing, along with the fear that even insured people won’t get the care they need because it’s too costly.